Tag: COVID-19

Biotech, Industry

COVID Pandemic Prompts Renewed Interest in Biotech Startups

January 12, 2022

Via: Biopharm International

The momentum of biotech and biopharma companies is on the rise in anticipation of a new wave of emerging therapies moving through the industry’s development pipeline. In addition, the COVID-19 pandemic highlighted the importance of companies that can react quickly […]

Industry, Vaccines

COVID-19 tracker: Pfizer-BioNTech booster expands its OK; Johnson & Johnson shot tackles omicron

January 4, 2022

Via: FiercePharma

The FDA further expanded the emergency use authorization for a booster shot of Pfizer-BioNTech’s Comirnaty. Johnson & Johnson’s COVID vaccine showed 85% efficacy against COVID-related hospitalization caused by omicron. The worldwide case count has risen to nearly 293 million Tuesday […]


What does the future hold for Biopharma?

December 29, 2021

Via: Abby Hallett

The COVID-19 pandemic has demonstrated that it is essential for biopharmaceutical organizations to act quickly and become flexible in production.  Experts, such as the CHEManager International team, view four factors as unsolved challenges. They claim that the first challenge is […]

FDA, Regulations

FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults

December 27, 2021

Via: World Pharma News

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for […]

Industry, Pharma

The Considered pharmaceutical marketing experiment

December 23, 2021

Via: Pharmaphorum

“There is some brilliant work that takes place by some incredibly intelligent agencies and individuals, but I know how formulaic we’ve become as an industry where next year’s tactics are probably very similar to this year’s tactics,” he says. “What […]

Biotech, Industry, News

2022 forecast: We wish we had better news for biotech dealmaking in 2022, but omicron is coming anyway

December 22, 2021

Via: FierceBiotech

We thought we’d finally get to see what a post-pandemic world looked like in 2022, but thanks to omicron, it seems we’re in for another round. Biotech has been shaped by the pandemic in ways that may be permanent, just […]

Industry, Vaccines

More Evidence Heart Risk From COVID Vaccine Is Very Low

December 21, 2021


There’s a very low risk of heart inflammation after getting the Pfizer and Moderna COVID-19 vaccines, according to a new study that adds to previous research supporting the safety of the shots. The two mRNA vaccines had been linked in […]

Industry, Vaccines

US prefers mRNA COVID-19 vaccines over J&J

December 20, 2021


The updated CDC advice follows a unanimous vote from its Advisory Committee on Immunization Practices (ACIP) which involved ‘a robust discussion of the latest evidence on vaccine effectiveness, vaccine safety and rare adverse events, and consideration of the US vaccine […]

Industry, Vaccines

Vaccines still provide ‘significant protection’ against severe COVID-19

December 15, 2021

Via: Pharma Times

COVID-19 vaccines appear to have become less effective in preventing severe COVID-19 disease and death, but they still provide ‘significant protection’, says the World Health Organisation (WHO), according to Reuters. The Omicron variant, first detected in South Africa and Hong […]


Regulation optimisation could save thousands of life years

December 14, 2021

Via: Pharmaphorum

Without “decisive action” cancer deaths across the European Union (EU) will increase by almost a quarter by 2035, making it the bloc’s leading cause of death. Expediating access to new treatments is key to avoiding this devastating outcome, according to […]


Booster COVID jabs offered to all adults in England

December 13, 2021

Via: Pharmaphorum

Westminster has promised additional support for the devolved administrations in Scotland, Wales and Northern Ireland to step up the booster campaign, and Scotland has already said it intends to match England’s target. The move comes as Prime Minister Boris Johnson […]

FDA, Regulations

FDA authorises Evusheld for COVID-19 prevention

December 9, 2021

Via: European Pharmaceutical Review

The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab and administered together) for the pre-exposure prophylaxis of COVID-19 in certain adults and paediatric individuals (12 years of age […]